Scioderm, Inc. clinical trials
Acquired by BioMarin Pharmaceutical, Apr 27, 2026 · source ↗
The registry lists 4 studies whose lead sponsor is Scioderm, Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Apr 9, 2020.
Before and after it joined BioMarin Pharmaceutical
- First submitted before Scioderm, Inc. became part of BioMarin Pharmaceutical
- 4
- First submitted after Scioderm, Inc. became part of BioMarin Pharmaceutical
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Scioderm, Inc.4 studies
Something wrong with this grouping? Tell us on the BioMarin Pharmaceutical page.
Studies
Recruiting first, then most recently updated. Showing 4 of 4. All BioMarin Pharmaceutical studies →
- ESSENCE Study: Efficacy and Safety of SD-101 Cream in Participants With Epidermolysis BullosaCompletedNCT02384460Phase 3
Sponsor listed in the registry: Scioderm, Inc. · First submitted before Scioderm, Inc. became part of BioMarin Pharmaceutical
- Study of Effectiveness and Safety of SD-101 in Participants With Epidermolysis BullosaCompletedNCT02014376Phase 2
Sponsor listed in the registry: Scioderm, Inc. · First submitted before Scioderm, Inc. became part of BioMarin Pharmaceutical
- Open-Label Extension Study to Evaluate the Safety of SD-101 Cream in Participants With Epidermolysis BullosaTerminatedNCT02090283Phase 2
Sponsor listed in the registry: Scioderm, Inc. · First submitted before Scioderm, Inc. became part of BioMarin Pharmaceutical
- Open Label Extension Study to Evaluate the Long-term Safety of Zorblisa (SD-101-6.0) in Patients With Epidermolysis BullosaTerminatedNCT02670330Phase 3
Sponsor listed in the registry: Scioderm, Inc. · First submitted before Scioderm, Inc. became part of BioMarin Pharmaceutical